Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : C3 ( CTHR ) Diamond in the rough? -- Ignore unavailable to you. Want to Upgrade?

To: dennis michael patterson who wrote (4)	11/15/1997 6:07:00 PM
From: glen	Read Replies (2) \| Respond to of 226

Leslie, The original "red herring" prospectus (as the initial one's are called) stated that 2 million shares would be issued at $13.50 /share. Increasing both the price and quantity changed it from a "hot" to a "cold", IPO. I cancelled my indication for C3 last Wednesday when I heard 3 million shares were to be sold. I would consider buying C3 on a dip. It does have long term potential to do well. I do view this, however, as a successful IPO, for both C3, and holders of CREE. Both companies will benefit from the capital that has been raised. It appears to me that the 3 Hunter brothers are attempting to work together in creating great value from their technology achievments in both of these companies. regards, glen

To: dennis michael patterson who wrote (4)	11/16/1997 3:34:00 AM
From: Leslie S. Feinberg	Read Replies (1) \| Respond to of 226

Dennis; C3 has the potential to take the material Cree uses to make it's commodity SiC products transformed into an extremely appealing, proprietarily manufactured gem unlike anything ever manufactured before and turn it into a sexy, very profitable business. 93% of professional jewelers can't tell C3 gems from high quality diamonds. By contrast any dummy can see that currently available diamond substitutes aren't even close. Cree is about 4 years old as a publicly traded stock. When C3 reaches this milestone it will long since have eclipsed Cree's performance IMHO. Les